Technology-assisted Index on Improving Hand Hygiene of Registered Nurses

September 7, 2020 updated by: National Taiwan University Hospital

The Effectiveness of Technology-assisted Index on Improving Hand Hygiene of Registered Nurses - An Experimental Research

In 2009, the World Health Organization (WHO) recommended the use of a multi-faceted, multi-modal hand hygiene strategy (Five Moments for Hand Hygiene) to improve hand hygiene compliance among healthcare staff. The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally. The novel coronavirus is characterized by rapid human-to-human transmission. Hand washing is a part of measures recommended by the World Health Organization (WHO) to avoid contracting COVID-19.The purpose of this study was to use adenosine triphosphate (ATP) testing and direct observation for improving hand hygiene and compliance in nurse.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Unknown

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The purpose of this study was to use adenosine triphosphate (ATP) testing and direct observation as technology-assisted index on improving hand hygiene and compliance in nurse.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
120

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Taiwan
      • Taipei, Taiwan, 10051, Taiwan
        • Recruiting
        • NTUH
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • (1)Day shift nurse on cancer ward,(2)who speak in Taiwanese and Mandarin,(3)and are willing to participate in the study.

Exclusion Criteria:

  • (1)There is any wound or scar on hand.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: control group
Participants in the control group will not receive the ATP testing result (pretest) immediately until finished the research.
Experimental: experimental group
Participants in the experimental group will be informed the ATP testing result (pretest) and receive the explanation by research assistant.
Behavioral: Technology-assisted Index
The participant will be informed the ATP testing result and explanation in pretest.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Demographics
Time Frame: Pre-test
gender, age, education, nursing job tenure, job tenure in ward
Pre-test
Knowledge of My 5 Moments for Hand Hygiene
Time Frame: Pre-test
The assessment consisted of 5 questions ,including (1)before touching a patient,(2)before clean/aseptic procedures,(3)after body fluid exposure/risk,(4)after touching a patient, (5)and after touching patient surroundings.The participant can get one point for a correct answer.Total scores range from 0 to 5.
Pre-test
Knowledge of My 5 Moments for Hand Hygiene (Post-test)
Time Frame: Immediately after completing the pre-test.
The assessment consisted of 5 questions ,including (1)before touching a patient,(2)before clean/aseptic procedures,(3)after body fluid exposure/risk,(4)after touching a patient, (5)and after touching patient surroundings.The participant can get one point for a correct answer.Total scores range from 0 to 5.
Immediately after completing the pre-test.
Frequency of performing My 5 Moments for Hand Hygiene
Time Frame: Pre-test
The assessment is a 5-point Likert scale with 5 items ,including (1)before touching a patient,(2)before clean/aseptic procedures,(3)after body fluid exposure/risk,(4)after touching a patient, (5)and after touching patient surroundings,from 1 to 5 that measure the frequency of performing the hand hygiene,so that higher scores indicate higher implementation of My 5 Moments for Hand Hygiene in the last week.
Pre-test
Frequency of performing My 5 Moments for Hand Hygiene (Post-test)
Time Frame: Immediately after completing the pre-test.
The assessment is a 5-point Likert scale with 5 items ,including (1)before touching a patient,(2)before clean/aseptic procedures,(3)after body fluid exposure/risk,(4)after touching a patient, (5)and after touching patient surroundings,from 1 to 5 that measure the frequency of performing the hand hygiene,so that higher scores indicate higher belief of conducting My 5 Moments for Hand Hygiene in the next week.
Immediately after completing the pre-test.
Attitude on hand hygiene
Time Frame: Pre-test
The assessment is a 5-point Likert scale with 1 items ,including the general attitude about the hand hygiene on working,so that higher scores indicate higher confident of hand hygiene.
Pre-test
Attitude on hand hygiene (Post-test)
Time Frame: Immediately after completing the pre-test.
The assessment is a 5-point Likert scale with 1 items ,including the general attitude about the hand hygiene on working,so that higher scores indicate higher confident of hand hygiene.
Immediately after completing the pre-test.
ATP testing
Time Frame: Pre-test
The 3M™ Clean-Trace™ Surface ATP test is a single-use test device that contains a swab for the collection of a sample from a surface. The swab is pre-moistened with a cationic agent to aid in the collection of soil and the release of Adenosine Tri-Phosphate (ATP) from intact cells.Upon activation of the test, reagent in the cuvette of the test device reacts with ATP collected on the swab to produce light.The intensity of the light is proportional to the amount of ATP and therefore the degree of contamination. Measurement of the light requires the use of a 3M™ Clean-Trace™ NG Luminometer and the results are displayed in Relative Light Units (RLU).ATP is an indicator of organic residues and microorganisms. Detection of ATP is used to rapidly assess the standards of hygiene and sanitation procedures for surfaces and equipment.
Pre-test
ATP testing (Post-test)
Time Frame: Immediately after completing the pre-test.
The 3M™ Clean-Trace™ Surface ATP test is a single-use test device that contains a swab for the collection of a sample from a surface. The swab is pre-moistened with a cationic agent to aid in the collection of soil and the release of Adenosine Tri-Phosphate (ATP) from intact cells.Upon activation of the test, reagent in the cuvette of the test device reacts with ATP collected on the swab to produce light.The intensity of the light is proportional to the amount of ATP and therefore the degree of contamination. Measurement of the light requires the use of a 3M™ Clean-Trace™ NG Luminometer and the results are displayed in Relative Light Units (RLU).ATP is an indicator of organic residues and microorganisms. Detection of ATP is used to rapidly assess the standards of hygiene and sanitation procedures for surfaces and equipment.
Immediately after completing the pre-test.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
National Taiwan University Hospital

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Wei-Wen Wu, PhD, National Taiwan University, College of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 10, 2020

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2022

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2022

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 5, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 9, 2020

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 11, 2020

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 9, 2020

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 7, 2020

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 202006019RINB

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings